MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0078565
Aura Pharmaceuticals Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹223.55 Cr
▲ 10% YoY
Net profit · FY 2025
₹8.5 Cr
Net margin 3.8%
EBITDA · FY 2025
₹12.43 Cr
EBITDA margin 5.6%
Authorised capital
₹51.3 Lakh
Registered with MCA
Paid-up capital
₹51.3 Lakh
Issued & subscribed
Open charges
₹16.62 Cr
Secured borrowings
Company age
17 yrs
Est. 2009
Employees · EPFO
76
Provident fund records
About Aura Pharmaceuticals Private Limited
Data last updated:
Aura Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 17 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2009PTC197919. Its GSTIN is 27AAICA1115H1Z2 (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹51.3 Lakh and a paid-up capital of ₹51.3 Lakh. It is led by directors including Altaf Abbasali Darediya and Sultanali Juma Mulani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 306 A – Wing Hari Om Plaza M. G. Road Borivali (East), Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2025, the company reported a revenue of ₹223.55 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹8.5 Cr (net margin 3.8%) and EBITDA of ₹12.43 Cr (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 18% over five years.
The company has about 76 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹16.62 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹26.2 Lakh; the latest was in March 2014. Its 6 peer companies in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Medopharm Private Limited with revenue of ₹229.32 Cr.
Aura Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0078565). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aurapharma.com.
Company details
CIN U24239MH2009PTC197919
Registration Number 197919
Incorporation Date 17 December 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0078565
Key People
Altaf Abbasali Darediya Director Sultanali Juma Mulani Director Suraj Mangalathu Viswanadhan Director Recognitions & Rankings of Aura Pharmaceuticals
Contact details
Aura Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is aurapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address306 A – Wing Hari Om Plaza M. G. Road Borivali (East), Mumbai, Maharashtra, India – 400066
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Aura Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Aura Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aura Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aura Pharmaceuticals Private Limited, buy the company report.
Financials of Aura Pharmaceuticals Private Limited
FY 2024 filings availableAura Pharmaceuticals Private Limited reported revenue of ₹223.55 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹223.55 Cr ▲ 10%
Net profit · FY 2025
₹8.5 Cr margin 3.8%
EBITDA · FY 2025
₹12.43 Cr margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 5%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▼ 7%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 10% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.5 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aura Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aura Pharmaceuticals Private Limited
Aura Pharmaceuticals has 8 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Altaf Abbasali Darediya Also directs: Anh Pharmaceuticals Private Limited | Director | 01 Apr 2025 | 1 Years 6 Months | Current |
| Sultanali Juma Mulani Also directs: Aura Lifecare Private Limited | Director | 02 Mar 2012 | 14 Years 7 Months | Current |
| Suraj Mangalathu Viswanadhan | Director | 14 Jul 2012 | 14 Years 3 Months | Current |
| Santosh Francis Dsouza Also directs: Aura Lifecare Private Limited | Director | 17 Dec 2009 | 16 Years 10 Months | Current |
| Aspak Amirbhai Mulani | Director | 01 Apr 2025 | 1 Years 6 Months | Current |
| Hamza Abbas Ali Sadikot | Director | 01 Apr 2025 | 1 Years 6 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Aura Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medopharm Private Limited | ₹229.32 Cr (FY 2025) | -9.0% | Chennai, Tamil Nadu, India | |||
| Hindustan Laboratories Limited | ₹227.37 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Aura Pharmaceuticals Private Limitedthis company | ₹223.55 Cr (FY 2025) | ₹8.5 Cr | 3.8% | 10.0% | 76 | Mumbai, Maharashtra, India |
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | 48.0% | Solan, Himachal Pradesh, India | |||
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | -29.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aura Pharmaceuticals Private Limited, buy the company report.
Auditor
Aura Pharmaceuticals Private Limited is audited by RAJIV N SHAH & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV N SHAH & ASSOCIATES LLP | FY 2023 | W100700 |
Shareholding
The shareholding of Aura Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aura Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16.62 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Aug 2021 | 100469289 | Others | ₹5.5 Cr | Open | |
| 25 Sep 2013 | 10455154 | Yes Bank Limited | ₹11.12 Cr | Open |
To see the full charge records of Aura Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Aura Pharmaceuticals Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹26.2 Lakh; the latest was in March 2014.
Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹26.2 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Sep 2012 | Funding round | ₹26.2 Lakh | Investors: 4 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aura Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Shalina Laboratories Private Limited | Pending |
To see the full case history of Aura Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aura Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aura Pharmaceuticals Private Limited has a workforce of 76 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
76
Active EPFO establishments
1
Employee growth
5.56%
GST
Aura Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICA1115H1Z2 | Maharashtra | Active | 01 Jul 2017 |
| 24AAICA1115H2Z7 | Gujarat | Active | 07 Mar 2019 |
To see the full GST registrations and return filing status of Aura Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aura Pharmaceuticals Private Limited has 13 board changes on record since 2009: 8 appointments and 5 cessations. The latest: Altaf Abbasali Darediya was appointed as Director on 01 Apr 2025.
Appointed
Altaf Abbasali Darediya was appointed as Director.
Appointed
Anil Abdulbhai Mulani was appointed as Director.
Appointed
Aspak Amirbhai Mulani was appointed as Director.
Appointed
Hamza Abbas Ali Sadikot was appointed as Director.
Appointed
Zoyef Barkatbhai Patni was appointed as Director.
AGM
Aura Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Aura Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Yes Bank Limited of Rs. 1,111.52 Lakh registered on 25 Sep 2013 with Charge ID 10455154 was modified on 03 Oct 2022.
Charges
A charge with Others amounted to Rs. 550.00 Lakh with Charge ID 100469289 was registered on 12 Aug 2021.
Ceased
Larissa Rose Fernandes Dsouza ceased to be Director.
Ceased
Barkatali Najarali Pattani ceased to be Director.
Ceased
Abdul Gulamhushen Mulani ceased to be Director.
7 earlier events are in the company report.
Frequently asked questions
Aura Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 17 December 2009 (17+ years old) and is registered under CIN U24239MH2009PTC197919.
Aura Pharmaceuticals has 8 current directors:
- Altaf Abbasali Darediya - Director
- Sultanali Juma Mulani - Director
- Suraj Mangalathu Viswanadhan - Director
- Santosh Francis Dsouza - Director
- Aspak Amirbhai Mulani - Director
- Hamza Abbas Ali Sadikot - Director
- Zoyef Barkatbhai Patni - Director
- Anil Abdulbhai Mulani - Director
The latest financial statements of Aura Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Aura Pharmaceuticals is 27AAICA1115H1Z2, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAICA1115H2Z7 (Gujarat).
The CIN (Corporate Identification Number) of Aura Pharmaceuticals is U24239MH2009PTC197919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aura Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Aura Pharmaceuticals was incorporated on 17 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Aura Pharmaceuticals has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹26.2 Lakh; the latest was in March 2014.
The peers of Aura Pharmaceuticals by revenue are Medopharm Private Limited, Hindustan Laboratories Limited, Salvi Chemical Industries Limited, Venus Biosciences Private Limited, Nestor Pharmaceuticals Limited and 1 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Altaf Abbasali Darediya was appointed as Director on 01 Apr 2025. Anil Abdulbhai Mulani was appointed as Director on 01 Apr 2025. Aspak Amirbhai Mulani was appointed as Director on 01 Apr 2025. Aura Pharmaceuticals has 13 board changes on record in total.
Yes, Aura Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0078565).